Cognitive training using virtual reality for children with brain tumors undergoing radiotherapy

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

Not applicable Interventional St. Jude Children's Research Hospital · NCT05947045

This study is testing whether virtual reality brain training can help children with brain tumors feel better while they receive radiotherapy compared to using an iPad for the same training.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment45 (estimated)
Ages8 Years to 22 Years
SexAll
SponsorSt. Jude Children's Research Hospital Academic / other
Drugs / interventionsradiation
Locations1 site (Memphis, Tennessee)
Trial IDNCT05947045 on ClinicalTrials.gov

What this trial studies

This study aims to evaluate the feasibility and acceptability of cognitive training delivered through virtual reality for children receiving radiotherapy for brain tumors. Participants will be randomly assigned to either virtual reality cognitive training or cognitive training via an iPad, with both groups undergoing cognitive assessments before and after the intervention. The study will also measure brain activity changes using functional near infrared spectroscopy (fNIRS) to assess neurocognitive benefits. The findings will inform the development of a larger, definitive study.

Who should consider this trial

Good fit: Ideal candidates are children aged 8-22 who are initiating radiotherapy for a brain tumor and can participate in cognitive training.

Not a fit: Patients with significant intellectual impairment or major neurological conditions prior to their brain tumor diagnosis may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could enhance cognitive function and improve the quality of life for children undergoing treatment for brain tumors.

How similar studies have performed: While the use of virtual reality for cognitive training is emerging, this specific approach in the context of pediatric brain tumor treatment is novel and has not been extensively tested.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Initiating radiotherapy for a BT
* Between 8-22 years of age at the time of enrollment
* English or Spanish as the primary language
* Research participant and one parent willing to participate and provide consent/assent according to institutional guidelines
* Participant willing to take part in required aspects of Cogmed training

Exclusion Criteria:

* Significant impairment in global intellectual functioning (estimated or full scale IQ \< 70 based on standardized testing routinely conducted on primary treatment protocols or as part of the New Oncology Program in Psychology \[NOPP\])
* History of significant neurological disease preceding BT diagnosis including stroke or head injury with loss of consciousness
* Major sensory or motor impairment that would preclude valid cognitive testing secondary to inability to complete study procedures (e.g., blindness, paresis, poorly controlled seizures/photosensitive epilepsy, inadequate balance to sit or stand unassisted to complete cognitive training)
* Psychiatric condition that would preclude or take precedence over study participation (e.g. active psychosis, suicidal ideation)
* Need for general anesthesia during radiation therapy (note: can participate if only sedated for simulation/planning but not daily treatment)

Where this trial is running

Memphis, Tennessee

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Brain TumorRadiotherapyBrain tumorCognitive trainingVirtual RealityWorking memory
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.